摘要
目的探讨右半腹腔脏器切除术在治疗腹膜后脂肪肉瘤中的可行性和安全性。方法回顾性分析2015年9月至2019年2月北京大学肿瘤医院软组织与腹膜后肿瘤中心行右半腹腔脏器切除术的16例腹膜后脂肪肉瘤患者的临床资料。结果16例患者均完整切除肿瘤,肿瘤中位最大直径29cm(13~43cm),中位手术时间660 min(429~940 min),中位术中出血量2000 ml(300~6000 ml)。术后Clavein-Dindo分级Ⅲ级以上并发症发生率为38%,中位总生存期41.0个月,中位无复发生存期32.6个月。结论右半腹腔脏器切除术有利于腹膜后脂肪肉瘤的完整切除,手术并发症可以控制。
Objective To investigate the feasibility and safety of right-sided abdominal evisceration in retroperitoneal liposarcoma.Methods The clinical data of 16 cases of retroperitoneal liposarcoma performed with right-sided abdominal evisceration at Sarcoma Center of Peking University Cancer Hospital from Sep 2015 to Feb 2019 were analyzed retrospectively.Results Complete resection were successfully performed in all 16 cases.The median tumor size was 29cm(13-43 cm),the median operative time was 660 min(429-940 min),the median estimated blood loss was 2000 ml(300-6000 ml).The major postoperative complications rate(Clavien-Dindo classificationⅢ-Ⅴ)was 38%.Median overall survival is 41.0 months while the median disease-free survival is 32.6 months.Conclusions Right-sided abdominal evisceration is a favorable procedure to attain complete resection with acceptable complication rate.
作者
李成鹏
吴剑挥
刘道宁
王震
王笑鹏
孙荣泽
侯枫桦
丘辉
吕昂
郝纯毅
Li Chengpeng;Wu Jianhui;Liu Daoning;Wang Zhen;Wang Xiaopeng;Sun Rongze;Hou Fenghua;Qiu Hui;Lyu Ang;Hao Chunyi(Sarcoma Center,Peking University Cancer Hospital&Institute,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Beijing 100142,China)
出处
《中华普通外科杂志》
CSCD
北大核心
2020年第6期439-442,共4页
Chinese Journal of General Surgery
基金
北京市医管局"登峰计划"人才团队(腹膜后肿瘤)资助项目(DFL20181104)。
关键词
脂肪肉瘤
腹膜后肿瘤
胰十二指肠切除术
联合器官切除
Liposarcoma
Retroperitoneal neoplasms
Pancreaticoduodenectomy
Multivisceral resection
